Trial Profile
Treatment with SGLT-2 inhibitor for postoperative hyperglycemia in acute abdominal surgery a randomized trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Dec 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Hyperglycaemia
- Focus Therapeutic Use
- 02 Dec 2021 New trial record